Follow
Stephan Holger Drukewitz
Stephan Holger Drukewitz
Verified email at uni-leipzig.de
Title
Cited by
Cited by
Year
Convergent evolution of the ladder-like ventral nerve cord in Annelida
C Helm, P Beckers, T Bartolomaeus, SH Drukewitz, I Kourtesis, A Weigert, ...
Frontiers in zoology 15, 1-17, 2018
672018
A dipteran’s novel sucker punch: Evolution of arthropod atypical venom with a neurotoxic component in robber flies (Asilidae, Diptera)
SH Drukewitz, N Fuhrmann, EAB Undheim, A Blanke, J Giribaldi, R Mary, ...
Toxins 10 (1), 29, 2018
412018
The significance of comparative genomics in modern evolutionary venomics
SH Drukewitz, BRM Von Reumont
Frontiers in Ecology and Evolution 7, 163, 2019
372019
Toxins from scratch? Diverse, multimodal gene origins in the predatory robber fly Dasypogon diadema indicate a dynamic venom evolution in dipteran insects
SH Drukewitz, L Bokelmann, EAB Undheim, BM von Reumont
GigaScience 8 (7), giz081, 2019
272019
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
A Jahn, A Rump, TJ Widmann, C Heining, P Horak, B Hutter, ...
Annals of Oncology 33 (11), 1186-1199, 2022
262022
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment
A Hennig, F Baenke, A Klimova, S Drukewitz, B Jahnke, S Brückmann, ...
The Journal of pathology 257 (5), 607-619, 2022
222022
Comparative analyses of glycerotoxin expression unveil a novel structural organization of the bloodworm venom system
S Richter, C Helm, FA Meunier, L Hering, LI Campbell, SH Drukewitz, ...
BMC Evolutionary Biology 17, 1-19, 2017
212017
Decoding single cell morphology in osteotropic breast cancer cells for dissecting their migratory, molecular and biophysical heterogeneity
L Bemmerlein, IA Deniz, J Karbanova, A Jacobi, S Drukewitz, T Link, ...
Cancers 14 (3), 603, 2022
102022
Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models
M Ullrich, S Richter, J Liers, S Drukewitz, M Friedemann, J Kotzerke, ...
Theranostics 13 (1), 278, 2023
72023
Combined systemic drug treatment with proton therapy: investigations on patient-derived organoids
M Naumann, T Czempiel, AJ Lößner, K Pape, E Beyreuther, S Löck, ...
Cancers 14 (15), 3781, 2022
72022
Treatment of pheochromocytoma cells with recurrent cycles of hypoxia: a new pseudohypoxic In vitro model
J Helm, S Drukewitz, I Poser, S Richter, M Friedemann, D William, H Mohr, ...
Cells 11 (3), 560, 2022
52022
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity
AA Wurm, S Brilloff, S Kolovich, S Schäfer, E Rahimian, V Kufrin, M Bill, ...
Cell Reports Medicine 4 (10), 2023
42023
Breaking the ladder: Evolution of the ventral nerve cord in Annelida
C Helm, P Beckers, T Bartolomaeus, SH Drukewitz, I Kourtesis, A Weigert, ...
BioRxiv, 378661, 2018
22018
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold
T Schmäche, J Fohgrub, A Klimova, K Laaber, S Drukewitz, F Merboth, ...
Molecular Cancer 23 (1), 10, 2024
12024
Clinical Impact of Polygenic Risk Score for Breast Cancer Risk Prediction in 382 Individuals with Hereditary Breast and Ovarian Cancer Syndrome
S Stiller, S Drukewitz, K Lehmann, J Hentschel, V Strehlow
Cancers 15 (15), 3938, 2023
12023
Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer
DM Klotz, FM Schwarz, A Dubrovska, K Schuster, M Theis, A Krüger, ...
Cancers 15 (15), 3774, 2023
12023
Chronic ER stress promotes cGAS/mtDNA-induced autoimmunity via ATF6 in myotonic dystrophy type 2
C Günther, S Rösing, F Ullrich, S Meisterfeld, F Schmidt, N Eberl, ...
12022
Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of ctDNA
O Kutz, S Drukewitz, A Krüger, D Aust, D William, S Oster, E Schröck, ...
Clinical Chemistry and Laboratory Medicine (CCLM), 2024
2024
Chronic endoplasmic reticulum stress in myotonic dystrophy type 2 promotes autoimmunity via mitochondrial DNA release
S Rösing, F Ullrich, S Meisterfeld, F Schmidt, L Mlitzko, M Croon, ...
Nature Communications 15 (1), 1534, 2024
2024
De novo variants in KDM2A cause a syndromic neurodevelopmental disorder-virtual
K Platzer, E Anderson, S Kour, D Rajan, S Schoennagel, LM Pilgram, ...
EUROPEAN JOURNAL OF HUMAN GENETICS 32, 8-9, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20